Why the study?
RV-PA coupling has gained interest for assessing RV dysfunction in HFpEF, but the clinical role and relative diagnostic accuracy of noninvasive measures require clarification.
Answers are grounded in this paper and cite their sources.
RV-PA coupling provides integrated prognostic information in HFpEF, but further prospective studies are needed to standardize noninvasive measurements and cutoff values for clinical practice.
Heart failure (HF) with preserved ejection fraction (HFpEF) is a common entity, characterized by the presence of symptoms and signs of HF despite having a normal or nearly normal left ventricular ejection fraction. The prevalence of HFpEF is increasing rapidly due to an aging population and the rising prevalence of risk factors such as obesity, diabetes, hypertension, and sleep apnea. In fact, HFpEF currently represents over half of the patients diagnosed with HF. Right ventricular (RV) dysfunction is common in patients with HFpEF. Not only does it contribute to the pathophysiology of HFpEF, but it is also a strong determinant of clinical outcomes in these patients. Several parameters are currently used for assessing RV function in clinical practice, including in patients with HFpEF. Of these, RV-pulmonary arterial (RV-PA) coupling measurement has gained considerable interest lately. By considering the right ventricle and pulmonary vascular system as an integrated functional unit, RV-PA coupling provides integrated information about the RV contractile response to the elevated afterload. Several studies have shown that RV-PA coupling is a useful measure of RV dysfunction in HFpEF, predicts adverse clinical outcomes, and may help inform treatment decisions. Although right heart catheterization is the gold standard technique for measuring RV-PA coupling, several echocardiography-based, noninvasive methods are also available. Various studies have demonstrated the accuracy and prognostic capability of these parameters. However, large-scale, prospective studies are needed to better define their role in day-to-day clinical practice, determine the relative diagnostic and prognostic accuracy of the various noninvasive measures of RV-PA coupling, and define the cutoff values predictive of adverse clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Hardeep Kaur Grewal (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: